I do agree with you buddy.
I personally have been monitoring TITXF for a long long time, and started to establish my play when the PPS was just below 0.2.
As Titan mentioned a few months ago, testings in three medical centres are the all essential and major operations needed for the FDA. However, in order to complete the software and training stuffs, they require min. 19.5M USD for the Q1 &Q2 in 2018, which are realistic but urgent issues.
According to Mc announced a few days ago, the current funding is sufficient for 2017, which in another word, money for 2018 is still in the air. If Mc has prepared sufficient funding to support the first few months of 2018, he definitely would have mentioned not just 2017, but 2018, or at least the beginning of 2018, to show more confidence to the market.
The reasons for the PPS increase from 0.9 to 0.49 in such short period of time are mainly the surgeon led investments, news from florida&Columbia PLUS warrant exercise. These news shows that Titan got enough funding for now and is just right on the scheduled milestones.
However, the warrant exercise always causes PPS drop for companies like Titan as the only reason for exercising warrant is to realise the investment return, especially large new share volume like this. And investors have and more investors will realise that titan can live for this year but no secured funding for next year, while 2018 requires extremely large funding.
There is just 1.5 month left before the Christmas holiday, if Titan fail to come up with a funding plan before the end of this year, 2018 milestone and PPS (and further warrant exercise in the future) are all in danger, regardless how many good news Titan can release.
